Mortality in children under 5 years of age with congenital syphilis in Brazil: A nationwide cohort study
Open Access
- 7 April 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 20 (4) , e1004209
Abstract
Background: Congenital syphilis (CS) is a major and avoidable cause of neonatal death worldwide. In this study, we aimed to estimate excess all-cause mortality in children under 5 years with CS compared to those without CS. Methods and findings: In this population-based cohort study, we used linked, routinely collected data from Brazil from January 2011 to December 2017. Cox survival models were adjusted for maternal region of residence, maternal age, education, material status, self-declared race and newborn sex, and year of birth and stratified according to maternal treatment status, non-treponemal titers and presence of signs and symptoms at birth. Over 7 years, a total of 20 057 013 live-born children followed up (through linkage) to 5 years of age, 93 525 were registered with CS, and 2 476 died. The all-cause mortality rate in the CS group was 7·84/1 000 person-years compared with 2·92/1 000 person-years in children without CS, crude hazard ratio (HR) = 2·41 (95% CI 2·31 to 2·50). In the fully adjusted model, the highest under-five mortality risk was observed among children with CS from untreated mothers HR = 2·82 (95% CI 2·63 to 3·02), infants with non-treponemal titer higher than 1:64 HR = 8·87 (95% CI 7·70 to 10·22), and children with signs and symptoms at birth HR = 7·10 (95% CI 6·60 to 7·63). Among children registered with CS, CS was recorded as the underlying cause of death in 33% (495/1 496) of neonatal, 11% (85/770) of postneonatal, and 2·9% (6/210) of children 1 year of age. The main limitations of this study were the use of a secondary database without additional clinical information and the potential misclassification of exposure status. Conclusions: This study showed an increased mortality risk among children with CS that goes beyond the first year of life. It also reinforces the importance of maternal treatment that infant non-treponemal titers and the presence of signs and symptoms of CS at birth are strongly associated with subsequent mortality. Trial registration: Observational study.Keywords
Funding Information
- CNPq (442873/2019-0)
- Bill and Melinda Gates Foundation (401739/2015-5)
- Wellcome Trust (202912/Z/16/Z)
- Wellcome Trust (213589/Z/18/Z)
This publication has 28 references indexed in Scilit:
- Sífilis materna e congênita, subnotificação e difícil controleRevista Brasileira de Epidemiologia, 2016
- Congenital syphilis: trends in mortality and morbidity in the United States, 1999 through 2013American Journal of Obstetrics and Gynecology, 2016
- Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance DataPLOS Medicine, 2013
- Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysisBulletin of the World Health Organization, 2013
- A review of diagnostic tests for congenital syphilis in newbornsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Syphilis is on the increase: the implications for child healthArchives of Disease in Childhood, 2008
- Estudo de confiabilidade do SINAN a partir das Campanhas para a Eliminação da Sífilis Congênita no Município do Rio de JaneiroRevista Brasileira de Epidemiologia, 2005
- Congenital syphilis: A guide to diagnosis and managementPaediatrics & Child Health, 2000
- Syphilis-associated perinatal and infant mortality in rural Malawi.1993
- Comparison of Maternal and Newborn Serologic Tests for SyphilisArchives of Pediatrics & Adolescent Medicine, 1991